FOLLOW US

  • facebook
  • twitter
Mon

March 9, 2026

Pfizer $41.5M Settlement

America November 19, 2025

Pfizer, Tris Pharma Reach $41.5M Settlement in Texas ADHD Drug Fraud Suit

Pharmaceutical giant Pfizer Inc. and Tris Pharma Inc. agreed Wednesday to pay $41.5 million to resolve explosive claims by the…

By Rihem Akkouche

Pfizer Weight-Loss $9B suit

America November 4, 2025

Pfizer Weight-Loss $9B Suit: Delaware Court Holds Off Amid High-Stakes Fight Over Metsera

In a dramatic twist in the Pfizer Weight-Loss $9B suit, a Delaware vice chancellor on Tuesday denied Pfizer Inc.’s emergency…

By Rihem Akkouche

Pfizer Sues Metsera

America November 1, 2025

Pfizer Sues Metsera to Block Novo Nordisk’s $9B “Bribe” Deal

In a dramatic escalation of a high-stakes biopharma showdown, Pfizer Inc. has filed suit in Delaware Chancery Court to stop…

By Rihem Akkouche

Metsera $9B buyout proposal

America October 30, 2025

Novo Nordisk Challenges Pfizer With Superior $9B Metsera Buyout Proposal

In a bold and unexpected twist in the pharmaceutical merger arena, Metsera Inc. announced Thursday that Novo Nordisk has submitted…

By Rihem Akkouche

Pfizer to acquire Metsera

America September 22, 2025

Pfizer to Acquire Metsera in $4.9B Bet on Obesity and Cardiometabolic Therapies

Pfizer Inc. is making a daring return to the obesity battlefield, announcing Monday that it will acquire Metsera Inc. for…

By Rihem Akkouche

Zantac Carcinogen Claims lawsuit

America January 27, 2025

U.S. Supreme Court Declines to Hear Zantac Carcinogen Claims Venue Dispute

The U.S. Supreme Court on Monday declined to review a Second Circuit decision holding that consolidated lawsuits against pharmaceutical companies…

By Rihem Akkouche

Zantac Cases Must Remain In State Court

America August 23, 2024

Zantac Cases Must Remain in State Court, Judge Rules

Connecticut state court litigation can move ahead for two groups of plaintiffs alleging that Zantac causes cancer and suing GlaxoSmithKline…

By Rihem Akkouche

America June 5, 2024

Zantac Cancer Suits Should Stay in Connecticut, Plaintiffs Argue

Lawsuits claiming Zantac and its generic equivalents caused cancer belong in Connecticut state court, two groups of Constitution State cancer…

By Rochdi Rais

Pharma Giants Urge SCOTUS to Reject Liability in $400M Terror-Funding Suit

America June 5, 2024

Pharma Giants Urge SCOTUS to Reject Liability in $400M Terror-Funding Suit

Pharmaceutical companies urged the U.S. Supreme Court on Tuesday to heed the federal government’s suggestion to throw out a D.C.…

By Rochdi Rais

Delaware judge lets more than 70,000 Zantac lawsuits go forward

America June 2, 2024

Delaware judge lets more than 70,000 Zantac lawsuits go forward

A Delaware judge has allowed more than 70,000 lawsuits regarding the discontinued heartburn drug Zantac to move forward. This decision,…

By Rihem Akkouche

Signup for the USA Herald
exclusive Newsletter